E-LIB Suche - Ergebnisse für: Scott, Boyd B

1

Combination Therapy With Infliximab and Azathioprine Is Sup..:

Panaccione, Remo ; Ghosh, Subrata ; Middleton, Stephen...
Gastroenterology. 146 (2014) 2 - p. 392-400.e3 , 2014

Link: https://doi.org/10.1053/..

2

Effect of odanacatib on bone turnover markers, bone density..:

Williams, Donald S. ; McCracken, Paul J. ; Purcell, Mona...
Bone. 56 (2013) 2 - p. 489-496 , 2013

Link: https://doi.org/10.1016/..

3

Effects of Odanacatib on BMD and Safety in the Treatment of..:

Bonnick, Sydney ; De Villiers, Tobias ; Odio, Alberto...
The Journal of Clinical Endocrinology & Metabolism. 98 (2013) 12 - p. 4727-4735 , 2013

Link: https://doi.org/10.1210/..

4

High-resolution peripheral quantitative computed tomography..:

Cabal, Antonio ; Jayakar, Richa Y. ; Sardesai, Swanand...
Bone. 56 (2013) 2 - p. 497-505 , 2013

Link: https://doi.org/10.1016/..

5

Odanacatib, a selective cathepsin K inhibitor to treat oste..:

Stoch, S. Aubrey ; Zajic, Stefan ; Stone, Julie A....
British Journal of Clinical Pharmacology. 75 (2013) 5 - p. 1240-1254 , 2013

Link: https://doi.org/10.1111/..

6

Evaluation of high-resolution peripheral quantitative compu..:

Jayakar, Richa Y. ; Cabal, Antonio ; Szumiloski, John...
Bone. 50 (2012) 6 - p. 1379-1388 , 2012

Link: https://doi.org/10.1016/..

7

Odanacatib reduces bone turnover and increases bone mass in..:

Masarachia, Patricia J ; Pennypacker, Brenda L ; Pickarski, Maureen...
Journal of Bone and Mineral Research. 27 (2011) 3 - p. 509-523 , 2011

Link: https://doi.org/10.1002/..

8

Odanacatib treatment increases hip bone mass and cortical t..:

Cusick, Tara ; Chen, Charles M ; Pennypacker, Brenda L...
Journal of Bone and Mineral Research. 27 (2011) 3 - p. 524-537 , 2011

Link: https://doi.org/10.1002/..

9

Structure-Based Design and Synthesis of 1,3-Oxazinan-2-one ..:

Xu, Zhenrong ; Tice, Colin M. ; Zhao, Wei...
Journal of Medicinal Chemistry. 54 (2011) 17 - p. 6050-6062 , 2011

Link: https://doi.org/10.1021/..

10

Biphenyl/diphenyl ether renin inhibitors: Filling the S1 po..:

Yuan, Jing ; Simpson, Robert D. ; Zhao, Wei...
Bioorganic & Medicinal Chemistry Letters. 21 (2011) 16 - p. 4836-4843 , 2011

Link: https://doi.org/10.1016/..

11

MK-0677 (ibutamoren mesylate) for the treatment of patients..:

Adunsky, Abraham ; Chandler, Julie ; Heyden, Norman...
Archives of Gerontology and Geriatrics. 53 (2011) 2 - p. 183-189 , 2011

Link: https://doi.org/10.1016/..

12

Variability of urodynamic parameters in patients with overa..:

Frenkl, Tara L. ; Railkar, Radha ; Palcza, John...
Neurourology and Urodynamics. 30 (2011) 8 - p. 1565-1569 , 2011

Link: https://doi.org/10.1002/..

13

Evaluation of an experimental urodynamic platform to identi..:

Frenkl, Tara ; Railkar, Radha ; Shore, Neal...
Neurourology and Urodynamics. 31 (2011) 1 - p. 69-74 , 2011

Link: https://doi.org/10.1002/..

14

Cathepsin K inhibitors prevent bone loss in estrogen-defici..:

Pennypacker, Brenda L ; Duong, Le T ; Cusick, Tara E...
Journal of Bone and Mineral Research. 26 (2010) 2 - p. 252-262 , 2010

Link: https://doi.org/10.1002/..

15

Spirocyclic ureas: Orally bioavailable 11β-HSD1 inhibitors ..:

Tice, Colin M. ; Zhao, Wei ; Xu, Zhenrong...
Bioorganic & Medicinal Chemistry Letters. 20 (2010) 3 - p. 881-886 , 2010

Link: https://doi.org/10.1016/..